Related by context. All words. (Click for frequent words.) 78 PFO migraine 74 phase IIb clinical 73 Phase IIIb clinical 71 Phase #b/#a clinical 71 phase IIa clinical 70 APEX PD 70 Phase IIB 69 Phase IIb III 69 EchoCRT 69 BioSTAR R 69 STARFlex ® 69 Phase 2b kidney transplant 68 CHAMPION PCI 68 phase IIIb 68 rALLy clinical trial 68 PFO closure 68 phase IIa 68 DSMB recommended 67 AIM HIGH 67 multicenter clinical 67 phase IIb trial 67 STARFlex R 67 MEND CABG II 67 IMPACT DCM clinical 67 STARFlex 67 Phase III confirmatory 67 confirmatory Phase III 67 confirmatory clinical 67 MEND CABG 67 Phase IIb kidney transplant 67 MADIT 66 BioSTAR ® 66 Phase III randomized controlled 66 Phase Ib clinical 66 STRIDE PD 66 placebo controlled clinical 66 placebo controlled Phase III 66 Phase Ib IIa 66 SEPET TM 66 ADVANCE PD 66 Phase 2b clinical 66 multicenter randomized controlled 66 MADIT II 66 SonoLysis 66 everolimus eluting stents 66 Randomized Evaluation 66 NeuroFlo 66 prospective multicenter randomized 66 RE LY 66 DEEP AF 66 OvaRex ® MAb 66 EVIZON TM 66 ENDEAVOR III 66 multicenter Phase 66 drug eluting coronary stent 66 GENASIS clinical 66 initiated Phase Ib 66 CARE HF 66 IIb clinical trial 65 evaluating Actimmune 65 Octreolin 65 oral ridaforolimus 65 multicenter Phase II 65 drug eluting stent DES 65 Phase 1a clinical 65 RE MODEL 65 multicenter prospective 65 refractory angina 65 Urocortin 2 65 BrachySil TM 65 Phase IIa trials 65 opioid induced bowel dysfunction 65 CUSTOM III 65 Cand5 65 CoAxia 65 PRECISE 65 Phase IIb clinical 65 MAGE A3 ASCI 65 Phase #b/#a 65 multicenter randomized clinical 65 randomized Phase IIb 65 Phase IIIb 65 Targretin capsules 64 ancrod 64 Pivotal Trial 64 BrachySil ™ 64 catheter occlusion 64 modified REGENESIS Phase IIb 64 HDL Selective Delipidation 64 Pivotal Clinical Trial 64 Zenvia ™ 64 APEX AMI trial 64 LUMINATE 64 Phase III Pivotal 64 prospective multicenter 64 lorcaserin Phase 64 TM Drug Eluting 64 SPIRIT FIRST 64 UPLYSO 64 carotid endarterectomy CEA 64 EmbraceAC 64 REMINYL ® 64 Dextofisopam 64 BRIM3 64 assessing T DM1 64 IL# PE#QQR 64 fosbretabulin 64 novel oral anticoagulant 64 PERSEUS clinical program 64 Viprinex 64 RELOVAIR ™ 64 prospective randomized multicenter 64 r hGH 64 ORBIT II 64 Viprinex TM 64 everolimus eluting stent 64 recurrent malignant glioma 64 PANVAC VF 64 ONTARGET 64 ExTRACT TIMI 64 COSIRA trial 64 Tarceva TM 64 Cimzia TM 64 TLK# 64 Drug Eluting Stent System 64 NSABP C 64 Phase III VISTA 64 ThermoDox ® clinical 64 reslizumab 64 ENGAGE AF TIMI 64 senicapoc 64 PRECISE trial 64 ZoMaxx 64 ABSORB trial 64 Phase Ib II 64 vidofludimus 64 YONDELIS 64 PF # [002] 64 MERLIN TIMI 64 Xcellerated T Cells 64 antiarrhythmic drug 64 RSD# oral 64 treat chronic sinusitis 64 CardioFit 64 Bicifadine 64 SUCCEED trial 64 Luveniq 64 PROMUS Element Stent 64 phase IIb 64 recurrent glioblastoma multiforme 63 Phase IIb trials 63 Lung Rx 63 elotuzumab 63 pivotal bioequivalence 63 PROMUS TM 63 fenretinide 63 CLARITY study 63 induced macular edema 63 Carotid Revascularization Endarterectomy vs. 63 Androxal TM 63 TAXUS Element Stent System 63 PRECISE Trial 63 BR.# 63 WallFlex Biliary RX 63 placebo controlled Phase 63 PROTECT AF 63 relapsing remitting MS RRMS 63 VITAL Trial 63 Phase 2a clinical 63 TASKi3 63 phase Ib clinical 63 LEUKINE 63 PHASE III 63 registrational Phase 63 PRIMO CABG2 63 Ascendra 63 PREVAIL 63 retinal vein occlusion induced 63 Fibrillex TM 63 multicenter randomized placebo controlled 63 PROMUS R 63 Phase III ADT 63 EDEMA3 63 Pivotal Phase III 63 chronic myocardial ischemia 63 systemic immunosuppressive drugs 63 randomized controlled multicenter 63 Neovasc Reducer 63 Daclizumab 63 Phase 2a trial 63 BRIM2 63 mg/m2 cohort 63 trastuzumab DM1 T DM1 63 eluting stent 63 multicenter Phase III 63 relapsing multiple sclerosis 63 RE LY ® 63 Phase III multicenter 63 ENDEAVOR IV 63 PROTEGE 63 vernakalant hydrochloride 63 IMC #B 63 PRIMO CABG 63 bortezomib Velcade 63 SYNERGY Stent 63 ZOLINZA 63 NYHA Class II 63 TEC #OL 63 placebo controlled randomized 63 Cypher Sirolimus 63 prospective randomized controlled 63 StemEx R 63 Phase IIb clinical trials 63 Phase III clinical 63 Alfimeprase 63 EURIDIS 63 Val HeFT 63 alvespimycin 63 eSVS MESH 63 interferon gamma 1b 63 Phase III HEAT 63 CA9 SCAN 63 novel VDA molecule 63 ReN# 63 mechanical thrombectomy 63 acyclovir Lauriad R 63 THALOMID 63 MelaFind R 63 PresbyLens ® 63 APEX AMI 63 Phase III ThermoDox 63 COSTAR II 63 IMPACT IMmunotherapy 63 AGILECT R 63 Edwards SAPIEN valve 63 VALOR trial 63 lomitapide 62 Vascular Wrap 62 TAXUS Liberte 62 ALN VSP Phase 62 BioSTAR TM 62 Cloretazine ® 62 Phase 1b clinical 62 ADMIRE HF 62 Xanafide 62 OvaRex R 62 double blinded placebo 62 Certolizumab pegol 62 Allovectin 7 62 incyclinide 62 Alvesco R 62 Zemplar Capsules 62 Cotavance 62 cystinosis patients 62 multicentre randomized 62 Initiate Phase 62 randomized controlled Phase 62 pain palliation 62 APPRAISE 62 fostamatinib 62 cangrelor 62 ularitide 62 Phase III pivotal 62 ATACAND 62 ENESTnd 62 NEVO 62 Intervention Effectiveness 62 Amoxicillin PULSYS Phase III 62 Phase #b/#a trial 62 GTC recombinant human 62 carotid stent 62 sargramostim 62 Plicera 62 budesonide foam 62 Pivotal Phase 62 CLIRS trial 62 Rubicon Filter 62 OvaRex 62 phase III isavuconazole 62 Silodosin 62 XIENCE V Everolimus Eluting 62 Randomized controlled 62 registrational 62 Dacogen injection 62 GAMMAGARD 62 fallopian tube cancers 62 Angiox ® 62 Dalbavancin 62 EVIZON TM squalamine lactate 62 PDE4 inhibitor 62 NO# [002] 62 iii GTx 62 multicenter clinical trials 62 randomized multicenter Phase III 62 EOquin TM 62 deforolimus 62 phase IIb III 62 candesartan cilexetil 62 Troxatyl 62 BST CarGel R 62 REGEN trial 62 R lenalidomide 62 CURE AF 62 severe hypercholesterolemia 62 Phase IIIb study 62 Rheos System 62 UVIDEM 62 ANCHOR trial 62 Fibrin Pad 62 hypoxia activated prodrug 62 ADP receptor antagonist 62 Traficet EN 62 Taxus Liberte stent 62 Mipomersen 62 dexanabinol 62 Phase 2b study 62 synthetic retinoid 62 docetaxel Taxotere ® 62 rALLy 62 dose escalation phase 62 LightTouch 62 Acute Myocardial Infarction 62 thorough QT 62 Anturol TM 62 Selective Electrochemical Tumor Ablation 62 Phase 1b dose escalation 62 oral deforolimus 62 NexStent 62 GP IIb IIIa inhibitor 62 Proellex TM 62 INTEGRILIN 62 Prospective Randomized 62 Ixempra 62 DEXILANT 62 HGS# 62 volociximab 62 paclitaxel eluting 62 Losartan 62 Acute Decompensated Heart Failure 62 Completes Patient Enrollment 62 TG MV 62 Phase 1b clinical trials 62 MGd 62 relapsed ALL 62 Levacor 62 SANVAR 62 rindopepimut 62 dose escalation Phase 62 Initiates Enrollment 62 ToGA 62 Phase IIa clinical 62 HCD# [002] 62 rhIGF-I/rhIGFBP-3 62 Canvaxin 62 ISTODAX 62 oral anticoagulant 62 OMNARIS Nasal Spray 62 GetGoal Phase III 62 Achieves Primary Endpoint 62 POSIDUR TM 61 multicentre randomized controlled 61 ThromCat 61 Ranolazine 61 immunotherapeutic vaccine 61 receptor tyrosine kinase inhibitor 61 generation purine nucleoside 61 substudy 61 brivaracetam 61 octreotide implant 61 CoreValve System 61 ONCONASE R 61 RELIANT 61 Emboshield 61 unstable angina UA 61 PRoFESS 61 successfully commercialize Iluvien 61 Vimpat R 61 European Sepsis Trial 61 Temsirolimus 61 confirmatory Phase 61 Percutaneous Transluminal Coronary Angioplasty 61 RX ACCULINK 61 ATTRACT 61 diabetic neuropathic pain 61 Diamondback #deg 61 Prostate AdenoCarcinoma Treatment 61 Generx TM 61 riociguat 61 fully bioabsorbable 61 novel histone deacetylase 61 initiate Phase 1b 61 landmark ATHENA 61 randomized multicentre 61 PROMUS Element 61 oral methylnaltrexone 61 initiate Phase IIa 61 dose escalation clinical 61 TAXUS TM 61 oral rivaroxaban 61 cortical stimulation 61 Cethrin 61 biliary tract cancer 61 SYMMETRY trial 61 ASCEND HF 61 BeneFIX 61 TAXUS Express Stent 61 tramiprosate Alzhemed TM 61 paclitaxel eluting stents 61 Bezielle 61 CIMZIA TM certolizumab pegol 61 Microplasmin 61 carotid artery stenting CAS 61 NAVISTAR R 61 EGS# 61 gamma secretase inhibitor 61 Medidur FA 61 TREDAPTIVE 61 glycoprotein IIb IIIa inhibitor 61 Thalomid ® 61 Initiates Phase II 61 interferon beta therapy 61 PrevOnco ™ 61 SCD HeFT 61 Tykerb lapatinib 61 Cloretazine 61 chronic thromboembolic pulmonary 61 MACUGEN 61 sorafenib Nexavar 61 forodesine 61 DCVax ® Brain 61 REVIVE Diabetes 61 OncoGel 61 inhaled AAT 61 NEVO RES 61 ofatumumab HuMax CD# 61 Specifid 61 xanthine oxidase inhibitor 61 GRAVITAS trial 61 Phase Ib study 61 RELIANT Trial 61 TMC# C# 61 PARTNER Trial 61 TELINTRA 61 coronary stenting 61 Stedivaze 61 ALSYMPCA 61 StemEx 61 Medidur TM FA 61 Fully Covered Stent 61 KRN# 61 patients undergoing percutaneous 61 NeuroSTAT ® 61 Investigational Device Exemption 61 evaluating tivozanib 61 PrevOnco 61 NEVO ™ 61 CRMD# 61 Severe Sepsis 61 RHEO 61 punctal plug 61 Vascugel ® 61 Multiple Ascending Dose 61 targeted radiotherapeutic 61 evaluating satraplatin 61 midstage clinical 61 delivery polymer matrix 61 Levacor TM 61 Phase lll 61 Ascendra transapical delivery 61 CHARM Added 61 MelaFind ® 61 Prestara 61 TASKi2 61 Orazol 61 PI3K/Akt pathway inhibitor 61 EFAPROXYN 61 Retisert TM 61 Phase IIb trial 61 MKC# MKC# PP 61 ASSURE 61 ARIXTRA 61 Embolic Protection System 61 dextromethorphan quinidine 61 Personalized Immunotherapy 61 ELACYT 61 Anti VEGF 61 dirucotide 61 rufinamide 61 nonrandomized 61 carotid revascularization 61 INCB# [001] 61 OmniWave 61 randomized blinded 61 apoptosis inducer 61 randomized controlled clinical 61 Combination REOLYSIN R 61 Atrasentan 61 DAPT Study 61 verteporfin 61 sirolimus eluting 61 ZYBRESTAT TM 61 Pyridorin 61 Onconase 61 Panzem R NCD 61 Initiates Phase III 61 Tasimelteon 61 VESTASYNC II trial 61 CytoFabTM 61 Ketotransdel 61 Rilonacept 61 Bayer HealthCare Onyx Pharmaceuticals 61 Dabigatran etexilate 61 cediranib 61 Degarelix 61 Angiox R 61 acadesine 61 COMFORT II 61 COPERNICUS 61 zileuton IV 61 percutaneous interventions 61 tolevamer 61 Phase III Clinical Trial 61 sitaxsentan 61 AVASTIN 61 ACOMPLIA R 61 GENASIS trial 61 Phase III psoriasis 61 NSABP B 61 NP2 Enkephalin 61 tezampanel NGX# 61 AIMM trial 61 CATIE AD 61 EnteroMedics proprietary neuroblocking technology 61 AQ4N 61 Cleviprex TM clevidipine 61 carotid artery stent 61 Elagolix 61 coronary stent merged 61 BCIRG 61 Carotid 61 TEMSO 61 dirucotide MBP# 61 cathepsin K inhibitor 61 Neuromodulation System 61 Vascular Wrap TM 60 refractory AML 60 carotid artery stenting 60 clinical pharmacology studies 60 Phase III Psoriasis 60 ASTEROID 60 TELCYTA 60 undergoing elective percutaneous 60 MIVI III 60 GENASIS 60 blood clot dissolver 60 BioMatrix TM 60 AERx 60 Endeavor drug eluting 60 lintuzumab SGN 60 R#/MEM 60 OMAPRO ™ 60 hoFH 60 GLP1 agonist 60 ZYBRESTAT fosbretabulin 60 DCVax R 60 secondary efficacy endpoint 60 ASSERT 60 AVONEX ® 60 anti arrhythmic drug 60 PROMUS 60 Abciximab 60 PRADAXA 60 IDE Investigational Device Exemption 60 FDA Investigational Device 60 somatostatin analog 60 rosuvastatin #mg 60 phase Ib 60 BRILINTA 60 metaglidasen 60 LibiGel Phase III 60 EP #R 60 ABSORB clinical 60 relapsed MM 60 Vectibix panitumumab 60 Dyloject TM 60 PREOS R 60 Initiated Phase 60 saphenous vein graft 60 platelet aggregation inhibitor 60 TAXUS Element Paclitaxel Eluting 60 HeartMate R 60 DU #b 60 PMA submission 60 HuMax TAC 60 Embolic Protection Device 60 Vernakalant 60 evaluating REVLIMID 60 Tesmilifene 60 mertansine 60 Recurrent Glioblastoma 60 Dural Sealant 60 phase IIb study 60 ACTIVE W 60 CALGB # [002] 60 Velcade bortezomib 60 Phase IIb REGENESIS 60 teriflunomide 60 AOD# [002] 60 acyclovir Lauriad ® 60 lapatinib Tykerb 60 TAXUS Liberte stent 60 comparing XIENCE V 60 BioNumerik 60 carotid stenting 60 Sibutramine Cardiovascular Outcomes 60 CONQUER OB 60 treatment naive genotype 60 ACUITY trial 60 Certican 60 Eluting Coronary Stent System 60 JAK inhibitor 60 Phase Ib clinical trials 60 TAXUS IV 60 SNT MC# 60 radiation sensitizer 60 MyoCell SDF 1 60 Zavesca r 60 Myocet 60 bucindolol 60 Endovascular System 60 symptomatic VTE 60 Phase IIb 60 implantable centrifugal rotary 60 AVERROES 60 LVAS 60 liposomal formulation 60 GW# [003] 60 PCA3 assay 60 histamine dihydrochloride 60 HoFH 60 Trofex 60 Phase 2b trial 60 multicentre prospective 60 Sirolimus eluting Coronary Stent 60 SurgiFrost 60 controlled multicenter Phase 60 AERx iDMS 60 gefitinib Iressa 60 miconazole Lauriad R 60 nalbuphine ER 60 SomatoKine 60 recurrent GBM 60 colesevelam HCl 60 Corlux 60 bardoxolone 60 AFRS TM 60 PSMA ADC 60 Arzerra TM 60 Azedra 60 EDEMA3 trial 60 PEARL SC 60 Pivotal Study 60 SPIRIT III 60 Hepatocellular Carcinoma HCC 60 HepeX B 60 Ophena TM 60 PRESEPT study 60 IIIa inhibitor 60 Multicenter 60 PLX STROKE targeting 60 BLP# Liposome Vaccine 60 paclitaxel eluting stent 60 Litx 60 Phase #/#a 60 Omigard 60 IIa trial 60 ENRICH trial 60 HCV RESPOND 2 60 GOUT 60 AZOR 60 Factor VIIa 60 SUPPRELIN R LA 60 Asentar 60 Intravitreal 60 inhaled formulation 60 STENT 60 Genasense ® oblimersen 60 Advaxis Phase 60 Saxagliptin 60 Tyrima 60 resectable pancreatic cancer 60 inhibitor RG# 60 EverFlex 60 Microwave Ablation System 60 Matrix Phase 2b 60 ACTEMRA TM 60 ARIXTRA R 60 Squalamine 60 dosing cohort 60 multicentre randomized double 60 ocrelizumab 60 dextofisopam 60 Abbokinase 60 Diabetic Macular Edema 60 Phase 1b trial 60 SIMPADICO 60 OLpur TM H2H 60 Immunotherapeutic 60 Corautus 60 Forodesine HCl 60 HVAD 60 engineered anticoagulant 60 Investigational Device Exemption IDE 60 Eliquis 60 controlled multicenter 60 relapsed refractory multiple myeloma 60 MitraClip device 60 orally administered inhibitor 60 reteplase 60 Aflibercept 60 PROVENGE ® 60 maximally tolerated 60 double blinded randomized 60 briakinumab 60 rotary VAD 60 Onalta ™ 60 multicenter placebo controlled 60 dalteparin 60 EXPLORE Xa 60 pregabalin Lyrica 60 BAY #-# 60 Phase III placebo controlled 60 CTO recanalization 60 Thrombolysis 60 Albuferon Phase 60 XL# SAR# 60 ACE inhibitor ramipril 60 OHR/AVR# 60 Thorough QT 60 CIMZIA R 60 patients undergoing CABG 60 BENICAR HCT 60 Clolar ® 60 Phase 2b clinical trials 60 peripherally acting 60 atacicept 60 TAXUS Liberte Stent 60 Dapagliflozin 60 BrainGate TM 60 MGCD# clinical trials 60 treat benign prostatic 60 regorafenib 60 squalamine 60 Civacir 60 Augment Injectable 60 LymphoStat B TM 60 pertuzumab 60 oral treprostinil 60 Stimuvax R 60 VNP#M 60 visilizumab 60 IMA# 60 AngioJet thrombectomy 60 NATRECOR R 60 PERSEUS 60 SUPERA stent 60 ENDEAVOR II 60 metastatic HRPC 60 MyoCell 60 Gentamicin Surgical Implant 60 polycythemia vera essential thrombocythemia 60 Trobalt 60 Laquinimod 60 REVLIMID lenalidomide 60 ONCASPAR 60 elective PCI 60 herpetic keratitis 60 Frova ® 60 cilengitide 60 Acute Ischemic Stroke 60 liver resection surgeries 60 SUTENT ® 60 AMEVIVE 60 Acute Coronary Syndromes ACS 59 non valvular atrial 59 icatibant 59 desvenlafaxine 59 Phase III randomized 59 coronary revascularization 59 trial evaluating PRX# 59 Cloretazine R VNP#M 59 OMNARIS HFA 59 VALSTAR 59 antiplatelet agent 59 vosaroxin 59 phase III ACCLAIM 59 pseudobulbar affect PBA 59 tanespimycin 59 blinded randomized placebo controlled 59 HCV SPRINT 59 number NCT# ClinicalTrials.gov 59 doxorubicin Transdrug ® 59 Syncria 59 DuraHeart 59 PROMUS Element Everolimus Eluting 59 Gabapentin GR 59 Neo Bladder Augment 59 pharmacodynamic PD 59 Myoblast 59 Meets Primary Endpoint 59 Triapine 59 Quinamed 59 GSK# [001] 59 coronary intervention 59 randomized Phase III 59 Deforolimus 59 ThermoDox R 59 TOLAMBA 59 NATRECOR ® 59 Aurexis 59 nitric oxide donating prostaglandin 59 Premarket Approval 59 ACCEDE 59 Bucindolol 59 FOLOTYN ® 59 evaluating mipomersen 59 Fentanyl TAIFUN R 59 REG1 59 BLOOM DM 59 transoral 59 prospective multicentre 59 generation rotary VAD 59 Alair System 59 Iloperidone 59 HuMax EGFr 59 Multicenter Automatic Defibrillator Implantation 59 Glypromate 59 Tanespimycin 59 TNFerade TM 59 hyaluronidase enzyme 59 randomized multicenter 59 candidate CRLX# 59 subcutaneous formulation 59 ARDIS 59 PRESEPT 59 Glycopyrrolate 59 CB2 selective receptor agonist 59 Custom NX 59 Urocidin 59 Dacogen decitabine 59 initiate multicenter 59 Phase III 59 aplindore 59 TRX1 59 bevasiranib 59 ponatinib 59 Liprostin 59 canakinumab 59 metastatic malignant 59 AERx ® 59 Solazed 59 Xerecept 59 PLAVIX ® 59 registrational trial 59 Zilver PTX stent 59 rALLy trial 59 HuMax CD4 59 Fondaparinux 59 EVIZON ™ 59 tiapamil 59 TORISEL 59 Prosaptide 59 Cellegesic 59 Nuvion 59 XIENCE V demonstrated 59 IPL# 59 NCT# ClinicalTrials.gov 59 HepaMate 59 E1 INT TM 59 alvimopan 59 Deferiprone 59 MoxDuo TM IR 59 multicenter randomized Phase 59 lexidronam injection 59 Tramiprosate ALZHEMED TM 59 treat atrial flutter 59 Canvaxin TM 59 pivotal Phase III 59 Xelox 59 cardiovascular hospitalizations 59 VBLOC vagal blocking 59 thienopyridine 59 Promus Element 59 phase III SIMPADICO 59 MYTHOS trial 59 ICA # 59 Motesanib 59 vinorelbine tartrate 59 MKC# 59 INSPIRE Trial Phase III 59 Amrubicin 59 Feasibility Trial 59 ATIR 59 omecamtiv mecarbil 59 antibody MAb 59 INTEGRILIN ® 59 bifurcation stent 59 personalized cellular immunotherapy 59 Ranibizumab 59 DUROS 59 Neulasta ® 59 Fx #A 59 REALITY Trial 59 AZX# Phase 59 confirmatory Phase 3 59 sunitinib malate 59 cutaneous T 59 FDA APPROVES 59 FOLFOX6 chemotherapy regimen 59 VBLOC TM 59 TMS Therapy 59 Virulizin R 59 Teriflunomide 59 sirolimus eluting stents 59 ROTATEQ 59 endothelin antagonist 59 Catena ® 59 Sorafenib HCC Assessment 59 Argatroban 59 CINTREDEKIN BESUDOTOX 59 XIENCE 59 REGENESIS Phase IIb 59 Phase 2a clinical trials 59 naproxen esomeprazole magnesium 59 docetaxel Taxotere R 59 Premarket Approval PMA 59 Diamyd R 59 BLA filing 59 Tavocept 59 rilonacept 59 compound INCB# 59 TM Everolimus Eluting 59 percutaneous aortic valve 59 direct thrombin inhibitor 59 ADAGIO study 59 AZILECT ® 59 Phase IIa trial 59 Long Lesion 59 CYT# potent vascular disrupting 59 thalidomide Thalomid 59 Phase 2a preventative 59 SinuNase 59 ALVESCO HFA 59 Anavex #-# 59 Ereska 59 CD HORIZON 59 STEDESA 59 prospective randomized placebo 59 Ocrelizumab 59 ARIKACE ™ 59 Pimavanserin 59 prospective randomized 59 mildly symptomatic 59 punctal plug delivery 59 transgenically produced product 59 LUX Lung 59 AdhTAP 59 GLIADEL R 59 cetrorelix pamoate 59 candidate XP# 59 MVax R 59 doxorubicin docetaxel 59 Novacor R 59 symptomatic paroxysmal AF 59 EOS NASDAQ MELA 59 SinuNase TM 59 Zenvia Phase III 59 QuadraSphere 59 6R BH4 59 Arsenic trioxide 59 Fludara ® 59 EVEREST II 59 Vorapaxar 59 Dextofisopam Phase 2b 59 orally inhaled migraine 59 Inhaled nitric oxide 59 RenalGuard System TM 59 bicifadine 59 PD2i Analyzer 59 ColonRing 59 MTWA testing 59 PREGNANT Study 59 oral talactoferrin 59 TRA 2P 59 arterial thrombosis 59 ARC# [002] 59 Torisel 59 Pemetrexed 59 Randomised